These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 16371574)

  • 1. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
    Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
    Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of and sequence choice for two oral contrast agents used during MR imaging.
    Grubnic S; Padhani AR; Revell PB; Husband JE
    AJR Am J Roentgenol; 1999 Jul; 173(1):173-8. PubMed ID: 10397122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?
    Vliegen RF; Beets GL; von Meyenfeldt MF; Kessels AG; Lemaire EE; van Engelshoven JM; Beets-Tan RG
    Radiology; 2005 Jan; 234(1):179-88. PubMed ID: 15550372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of magnetic resonance in characterising extrahepatic cholangiocarcinomas.
    Guarise A; Venturini S; Faccioli N; Pinali L; Morana G
    Radiol Med; 2006 Jun; 111(4):526-38. PubMed ID: 16779539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The staging of bladder tumors in MRT: the value of the intravesical application of an iron oxide-containing contrast medium in combination with high-resolution T2-weighted imaging].
    Beyersdorff D; Taupitz M; Giessing M; Türk I; Schnorr D; Loening S; Hamm B
    Rofo; 2000 Jun; 172(6):504-8. PubMed ID: 10916545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Crohn disease activity with magnetic resonance imaging.
    Maccioni F; Viscido A; Broglia L; Marrollo M; Masciangelo R; Caprilli R; Rossi P
    Abdom Imaging; 2000; 25(3):219-28. PubMed ID: 10823437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing metallic artifacts in postoperative spinal imaging: usefulness of IDEAL contrast-enhanced T1- and T2-weighted MR imaging--phantom and clinical studies.
    Cha JG; Jin W; Lee MH; Kim DH; Park JS; Shin WH; Yi BH
    Radiology; 2011 Jun; 259(3):885-93. PubMed ID: 21386053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-enhanced MR imaging of temporomandibular disorders: improved lesion detection of the posterior disk attachment on T1-weighted images obtained with fat suppression.
    Suenaga S; Abeyama K; Noikura T
    AJR Am J Roentgenol; 1998 Aug; 171(2):511-7. PubMed ID: 9694485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers and MR imaging findings as predictors of crohn disease activity in patients scanned by contrast-enhanced MR enterography.
    Quaia E; Cabibbo B; Sozzi M; Gennari AG; Pontello M; Degrassi F; Cova MA
    Acad Radiol; 2014 Oct; 21(10):1225-32. PubMed ID: 24998692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
    Yasumoto M; Shibuya H; Takeda M; Korenaga T
    AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features.
    Punwani S; Rodriguez-Justo M; Bainbridge A; Greenhalgh R; De Vita E; Bloom S; Cohen R; Windsor A; Obichere A; Hansmann A; Novelli M; Halligan S; Taylor SA
    Radiology; 2009 Sep; 252(3):712-20. PubMed ID: 19635832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of the inner ear and cerebellopontine angle: comparison of three-dimensional and two-dimensional sequences.
    Czerny C; Rand T; Gstoettner W; Woelfl G; Imhof H; Trattnig S
    AJR Am J Roentgenol; 1998 Mar; 170(3):791-6. PubMed ID: 9490977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn disease with endoscopic correlation: single-shot fast spin-echo and gadolinium-enhanced fat-suppressed spoiled gradient-echo MR imaging.
    Low RN; Sebrechts CP; Politoske DA; Bennett MT; Flores S; Snyder RJ; Pressman JH
    Radiology; 2002 Mar; 222(3):652-60. PubMed ID: 11867781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.